Original Research

Published on 05 Nov 2024

Mex3a promoter hypomethylation can be utilized to diagnose HBV-associated hepatocellular carcinoma: a randomized controlled trial

in Gastrointestinal and Hepatic Pharmacology

Jie-Ru Yang
Yu-Xin Tian
Jin-E. Li
Ying Zhang
Yu-Chen Fan
Kai Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1325869

396 views

Original Research

Published on 28 Oct 2024

Modulation of Notch signaling pathway in activated hepatic stellate cells does not ameliorate the outcome of liver fibrosis in carbon tetrachloride and DDC-feeding models

in Gastrointestinal and Hepatic Pharmacology

Dino Šisl
Pavao Planinić
Sanja Novak
Maša Filipović
Darja Flegar
Alan Šućur
Petra Turčić
Nataša Kovačić
Ivo Kalajzić
Danka Grčević

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1440236

556 views

Review

Published on 24 Oct 2024

Flavonoids in natural products for the therapy of liver diseases: progress and future opportunities

in Gastrointestinal and Hepatic Pharmacology

Yanmei Liao
Fei Lv
Tianwen Quan
Chuan Wang
Jike Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485065

687 views

Original Research

Published on 24 Oct 2024

Multi-omics reveals the alleviating effect of berberine on ulcerative colitis through modulating the gut microbiome and bile acid metabolism in the gut-liver axis

in Gastrointestinal and Hepatic Pharmacology

Jingsheng Yu
Yixuan Zheng
Changmin Liu
Zhuangyuan Xie
Qingqing Liu
Shuai Yang
Qianqian Tian
Chi Song
Shilin Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1494210

642 views

Original Research

Published on 22 Oct 2024

GYY4137, as a slow-releasing H2S donor, ameliorates sodium deoxycholate–induced chronic intestinal barrier injury and gut microbiota dysbiosis

in Gastrointestinal and Hepatic Pharmacology

Shaorong Pan
Han Yan
Jing Zhu
Yuanyuan Ma
Pengyuan Wang
Yucun Liu
Zeyang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1476407

801 views

Systematic Review

Published on 17 Oct 2024

Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: a network meta-analysis of randomized controlled trials

in Gastrointestinal and Hepatic Pharmacology

Hong Duo
Yanwei Yang
Guqing Zhang
Yingxin Chen
Yumeng Cao
Linjie Luo
Huaqin Pan
Qifa Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1430724

1,236 views

Review

Published on 16 Oct 2024

Retinoid X receptor heterodimers in hepatic function: structural insights and therapeutic potential

in Gastrointestinal and Hepatic Pharmacology

Renjie Xu
Linyue Zhang
Hao Pan
Yong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1464655

878 views

Original Research

Published on 16 Oct 2024

Effectiveness of biologic therapies in achieving treatment targets in inflammatory bowel disease; real-world data from the Middle East (ENROLL study)

in Gastrointestinal and Hepatic Pharmacology

Mohammad Shehab
Ahmad Alfadhli
Israa Abdullah
Wrood Alostad
Alaa Marei
Fatema Alrashed

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388043

758 views

Editorial

Published on 09 Oct 2024

Editorial: Probiotics and their metabolites in cancer therapy

in Gastrointestinal and Hepatic Pharmacology

Pourya Gholizadeh
Amir Hossein Faghfouri
Pio Maria Furneri
Elnaz Faghfuri

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1497524

435 views

Systematic Review

Published on 08 Oct 2024

Worldwide research trends in Crohn’s disease treatment over the past 2 decades: a bibliometric analysis

in Gastrointestinal and Hepatic Pharmacology

Likang Xu
Jinzhao Zou
Chao Sun
Gong Chen
Sujun Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1441785

1,035 views

Original Research

Published on 08 Oct 2024

Mouse liver sinusoidal endothelial cell responses to the glucocorticoid receptor agonist dexamethasone

in Gastrointestinal and Hepatic Pharmacology

Sabin Bhandari
Ingelin Kyrrestad
Jaione Simón-Santamaría
Ruomei Li
Karolina Joanna Szafranska
Gianina Dumitriu
Javier Sánchez Romano
Bård Smedsrød
Karen Kristine Sørensen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377136

974 views

Original Research

Published on 07 Oct 2024

Impact of albumin infusion on prognosis in ICU patients with cirrhosis and AKI: insights from the MIMIC-IV database

in Gastrointestinal and Hepatic Pharmacology

Mengqi Li
Yidi Ge
Jingjing Wang
Wenya Chen
Jiashuo Li
You Deng
Wen Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1467752

1,050 views

Mini Review

Published on 30 Sep 2024

The role of autophagy in pancreatic diseases

in Gastrointestinal and Hepatic Pharmacology

Wen-Gang Zhang
Qing-Zhen Wu
Bo-Zong Shao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1444657

827 views

Review

Published on 20 Sep 2024

Appraisal of postbiotics in cancer therapy

in Gastrointestinal and Hepatic Pharmacology

Aruna Senthil Kumar Sudaarsan
Asit Ranjan Ghosh

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1436021

1,175 views

Original Research

Published on 19 Sep 2024

Construction of an interpretable model for predicting survival outcomes in patients with middle to advanced hepatocellular carcinoma (≥5 cm) using lasso-cox regression

in Gastrointestinal and Hepatic Pharmacology

Han Li
Bo Yang
Chenjie Wang
Bo Li
Lei Han
Yi Jiang
Yanqiong Song
Lianbin Wen
Mingyue Rao
Jianwen Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1452201

756 views

Original Research

Published on 18 Sep 2024

Emodin repairs interstitial cells of Cajal damaged by cholelithiasis in the gallbladder

in Gastrointestinal and Hepatic Pharmacology

Zhen-peng Huang
Hu Qiu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1424400

553 views

Navigation group

Articles

Mex3a promoter hypomethylation can be utilized to diagnose HBV-associated hepatocellular carcinoma: a randomized controlled trial

Modulation of Notch signaling pathway in activated hepatic stellate cells does not ameliorate the outcome of liver fibrosis in carbon tetrachloride and DDC-feeding models

Flavonoids in natural products for the therapy of liver diseases: progress and future opportunities

Multi-omics reveals the alleviating effect of berberine on ulcerative colitis through modulating the gut microbiome and bile acid metabolism in the gut-liver axis

GYY4137, as a slow-releasing H2S donor, ameliorates sodium deoxycholate–induced chronic intestinal barrier injury and gut microbiota dysbiosis

Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: a network meta-analysis of randomized controlled trials

Retinoid X receptor heterodimers in hepatic function: structural insights and therapeutic potential

Effectiveness of biologic therapies in achieving treatment targets in inflammatory bowel disease; real-world data from the Middle East (ENROLL study)

Editorial: Probiotics and their metabolites in cancer therapy

Worldwide research trends in Crohn’s disease treatment over the past 2 decades: a bibliometric analysis

Mouse liver sinusoidal endothelial cell responses to the glucocorticoid receptor agonist dexamethasone

Impact of albumin infusion on prognosis in ICU patients with cirrhosis and AKI: insights from the MIMIC-IV database

The role of autophagy in pancreatic diseases

Appraisal of postbiotics in cancer therapy

Construction of an interpretable model for predicting survival outcomes in patients with middle to advanced hepatocellular carcinoma (≥5 cm) using lasso-cox regression

Emodin repairs interstitial cells of Cajal damaged by cholelithiasis in the gallbladder